We are live on ! Find out more
VIR icon

Vir Biotechnology
VIR

209 hedge funds and large institutions have $901M invested in Vir Biotechnology in 2024 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 71 increasing their positions, 68 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 27

13% more call options, than puts

Call options by funds: $3.04M | Put options by funds: $2.7M

1% more funds holding

Funds holding: 206 → 209 (+3)

4% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 68

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1% less capital invested

Capital invested by funds: $909M → $901M (-$7.72M)

1.31% less ownership

Funds ownership: 67.13% → 65.83% (-1.3%)

Holders
209
Holders Change
+3
Holders Change %
+1.46%
% of All Funds
3.01%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
31
Increased
71
Reduced
68
Closed
27
Calls
$3.04M
Puts
$2.7M
Net Calls
+$342K
Net Calls Change
-$1M

Top Buyers

1
Bank of America
Bank of America
North Carolina
+$10M
2
Citigroup
Citigroup
New York
+$9.36M
3
Barclays
Barclays
United Kingdom
+$5.8M
4
O
OrbiMed
New York
+$5.49M
5
Citadel Advisors
Citadel Advisors
Florida
+$3.77M

Top Sellers

1
AllianceBernstein
AllianceBernstein
Tennessee
-$27.2M
2
Morgan Stanley
Morgan Stanley
New York
-$19.5M
3
Prudential Financial
Prudential Financial
New Jersey
-$3.29M
4
TC
TwinBeech Capital
New York
-$3.22M
5
BlackRock
BlackRock
New York
-$3.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
ProShare Advisors
101
ProShare Advisors
Maryland
$267K +$20.7K +2,035 +8%
AQR Capital Management
102
AQR Capital Management
Connecticut
$264K +$56.7K +5,566 +27%
CUAMC
103
China Universal Asset Management Company
China
$263K +$106K +10,414 +67%
Russell Investments Group
104
Russell Investments Group
United Kingdom
$263K +$142K +13,981 +117%
ASRS
105
Arizona State Retirement System
Arizona
$262K -$3.99K -392 -1%
MSRPS
106
Maryland State Retirement & Pension System
Maryland
$260K -$6.36K -624 -2%
BCM
107
Bayesian Capital Management
New York
$259K +$261K +25,600 New
DTL
108
Dynamic Technology Lab
Singapore
$250K +$251K +24,626 New
Mitsubishi UFJ Asset Management
109
Mitsubishi UFJ Asset Management
Japan
$243K -$11.2K -1,099 -4%
TRSOTSOK
110
Teachers Retirement System of the State of Kentucky
Kentucky
$239K – – –
OPERF
111
Oregon Public Employees Retirement Fund
Oregon
$234K -$21.4K -2,100 -8%
CIC
112
Cornercap Investment Counsel
Georgia
$231K +$105K +10,320 +83%
FRM
113
Fox Run Management
Connecticut
$229K +$230K +22,567 New
Handelsbanken Fonder
114
Handelsbanken Fonder
Sweden
$228K – – –
SSA
115
Schonfeld Strategic Advisors
New York
$227K +$228K +22,366 New
Creative Planning
116
Creative Planning
Kansas
$221K +$47.4K +4,657 +27%
Zurich Cantonal Bank
117
Zurich Cantonal Bank
Switzerland
$217K +$21.3K +2,089 +11%
Bank of Montreal
118
Bank of Montreal
Ontario, Canada
$212K +$63.3K +6,213 +42%
Teacher Retirement System of Texas
119
Teacher Retirement System of Texas
Texas
$212K -$4.83K -474 -2%
EFM
120
E Fund Management
China
$210K -$6.76K -664 -3%
OA
121
Oracle Alpha
Ontario, Canada
$207K +$13.9K +1,368 +7%
HSBC Holdings
122
HSBC Holdings
United Kingdom
$189K -$31.7K -3,109 -14%
COPPSERS
123
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$188K +$143 +14 +0.1%
YIH
124
Y-Intercept (HK)
Hong Kong
$186K +$187K +18,320 New
Ohio Public Employees Retirement System (OPERS)
125
Ohio Public Employees Retirement System (OPERS)
Ohio
$179K -$4.17K -409 -2%
3 4
5
6 7

VIR Hedge Fund Activity: Q1 2024 in Review

209 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Vir Biotechnology (VIR) for Q1 2024, worth a combined $901M — down 0.85% from $909M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new VIR positions and 27 closed out — a net gain of 4 holders — while 71 added to existing stakes and 68 trimmed.

The largest buyer was Bank of America, adding an estimated $10M. The largest seller was AllianceBernstein, cutting an estimated $27.2M.

  • 209 institutional investors held Vir Biotechnology (VIR) as of Q1 2024, up from 206 in Q4 2023.
  • Funds reported $901M of Vir Biotechnology stock for Q1 2024, down 0.85% quarter-over-quarter.
  • 31 funds opened new Vir Biotechnology positions in Q1 2024 and 27 closed out, a net change of +4 holders.
  • The largest Vir Biotechnology buyer in Q1 2024 was Bank of America, an estimated $10M added.
  • The largest Vir Biotechnology seller in Q1 2024 was AllianceBernstein, an estimated $27.2M sold.

Based on aggregated 13F filings for Q1 2024.